These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1092 related articles for article (PubMed ID: 26358617)

  • 1. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest advances in molecular topology applications for drug discovery.
    Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
    Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
    Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
    Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
    Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
    Speck-Planche A; Cordeiro MN
    Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-QSAR and molecular docking for the discovery of ketolide derivatives.
    Ruan ZX; Huangfu DS; Xu XJ; Sun PH; Chen WM
    Expert Opin Drug Discov; 2013 Apr; 8(4):427-44. PubMed ID: 23441865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic generation of chemical structures for rational drug design based on QSAR models.
    Funatsu K; Miyao T; Arakawa M
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4D- quantitative structure-activity relationship modeling: making a comeback.
    Fourches D; Ash J
    Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines.
    Galvez J; Galvez-Llompart M; Zanni R; Garcia-Domenech R
    Expert Opin Drug Discov; 2013 Mar; 8(3):305-17. PubMed ID: 23289365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges with multi-objective QSAR in drug discovery.
    Lambrinidis G; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2018 Sep; 13(9):851-859. PubMed ID: 29996683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents.
    Ambure P; Roy K
    Expert Opin Drug Discov; 2014 Jun; 9(6):697-723. PubMed ID: 24754675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances with support vector machines for novel drug discovery.
    Maltarollo VG; Kronenberger T; Espinoza GZ; Oliveira PR; Honorio KM
    Expert Opin Drug Discov; 2019 Jan; 14(1):23-33. PubMed ID: 30488731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
    Bellera CL; Talevi A
    Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
    [No Abstract]   [Full Text] [Related]  

  • 17. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
    Singh K; Bhushan B; Singh B
    Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-similarity-based QSAR (FS-QSAR) algorithm for ligand biological activity predictions.
    Myint KZ; Ma C; Wang L; Xie XQ
    SAR QSAR Environ Res; 2011 Jun; 22(3):385-410. PubMed ID: 21598200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
    Dobchev D; Karelson M
    Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.